Annual Total Long Term Liabilities
$6.01 M
-$1.13 M-15.82%
30 April 2024
Summary:
KalVista Pharmaceuticals annual total long term liabilities is currently $6.01 million, with the most recent change of -$1.13 million (-15.82%) on 30 April 2024. During the last 3 years, it has risen by +$969.00 thousand (+19.20%). KALV annual total long term liabilities is now -86.25% below its all-time high of $43.73 million, reached on 31 December 2014.KALV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$4.99 M
-$1.03 M-17.07%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly total long term liabilities is currently $4.99 million, with the most recent change of -$1.03 million (-17.07%) on 31 July 2024. Over the past year, it has dropped by -$1.56 million (-23.80%). KALV quarterly long term liabilities is now -89.08% below its all-time high of $45.68 million, reached on 31 March 2015.KALV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | -23.8% |
| 3 y3 years | +19.2% | -19.9% |
| 5 y5 years | +80.0% | +31.0% |
KALV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.6% | +19.2% | -37.8% | at low |
| 5 y | 5 years | -16.6% | +469.1% | -37.8% | +435.2% |
| alltime | all time | -86.3% | -89.1% |
KalVista Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $4.99 M(-17.1%) |
| Apr 2024 | $6.01 M(-15.8%) | $6.01 M(-3.9%) |
| Jan 2024 | - | $6.26 M(-4.4%) |
| Oct 2023 | - | $6.55 M(-4.6%) |
| July 2023 | - | $6.87 M(-3.9%) |
| Apr 2023 | $7.14 M(-0.9%) | $7.14 M(-3.7%) |
| Jan 2023 | - | $7.42 M(-3.7%) |
| Oct 2022 | - | $7.71 M(-3.9%) |
| July 2022 | - | $8.01 M(+11.1%) |
| Apr 2022 | - | $7.21 M(-3.4%) |
| Apr 2022 | $7.21 M(+42.9%) | - |
| Jan 2022 | - | $7.47 M(+20.0%) |
| Oct 2021 | - | $6.22 M(-3.9%) |
| July 2021 | - | $6.47 M(+28.3%) |
| Apr 2021 | $5.05 M(+377.4%) | $5.05 M(+349.3%) |
| Jan 2021 | - | $1.12 M(+20.5%) |
| Oct 2020 | - | $932.00 K(-7.7%) |
| July 2020 | - | $1.01 M(-4.4%) |
| Apr 2020 | $1.06 M(-68.4%) | $1.06 M(-69.1%) |
| Jan 2020 | - | $3.43 M(-10.0%) |
| Oct 2019 | - | $3.81 M(-6.0%) |
| July 2019 | - | $4.05 M(+21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2019 | $3.34 M(-69.4%) | $3.34 M(-8.8%) |
| Jan 2019 | - | $3.67 M(-21.5%) |
| Oct 2018 | - | $4.67 M(-44.8%) |
| July 2018 | - | $8.46 M(-22.5%) |
| Apr 2018 | $10.92 M(>+9900.0%) | $10.92 M(-22.0%) |
| Jan 2018 | - | $14.01 M(+9300.0%) |
| Oct 2017 | - | $149.00 K(-30.0%) |
| July 2017 | - | $213.00 K(>+9900.0%) |
| Apr 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2017 | - | $0.00(-100.0%) |
| Sept 2016 | - | $35.00 K(-16.7%) |
| June 2016 | - | $42.00 K(-98.5%) |
| Apr 2016 | $0.00(-100.0%) | - |
| Mar 2016 | - | $2.75 M(-14.3%) |
| Dec 2015 | $3.21 M(-92.7%) | $3.21 M(-12.4%) |
| Sept 2015 | - | $3.67 M(-10.8%) |
| June 2015 | - | $4.11 M(-91.0%) |
| Mar 2015 | - | $45.68 M(+4.4%) |
| Dec 2014 | $43.73 M(+9.7%) | $43.73 M(+1.9%) |
| Sept 2014 | - | $42.94 M(+7.7%) |
| Dec 2013 | $39.86 M(+18.1%) | $39.86 M |
| Dec 2012 | $33.75 M | - |
FAQ
- What is KalVista Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual total long term liabilities year-on-year change?
- What is KalVista Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly long term liabilities year-on-year change?
What is KalVista Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of KALV is $6.01 M
What is the all time high annual total long term liabilities for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual total long term liabilities is $43.73 M
What is KalVista Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, KALV annual total long term liabilities has changed by -$1.13 M (-15.82%)
What is KalVista Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of KALV is $4.99 M
What is the all time high quarterly long term liabilities for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly total long term liabilities is $45.68 M
What is KalVista Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, KALV quarterly total long term liabilities has changed by -$1.56 M (-23.80%)